Steep cuts at the Food and Drug Administration might slow down drug approvals vital to the biopharma industry.
Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...
With this funding, Entvin plans to expand its artificial intelligence capabilities and accelerate customer acquisition ...
3h
Health on MSNFDA Says Ozempic Is No Longer in Shortage—Does That Mean the End of Cheaper Copycat Versions?Fact checked by Nick Blackmer Compounded versions of semaglutide, the active ingredient in weight loss drugs like Ozempic and ...
After months of back and forth and uncertainty related to efforts under the new Trump Administration to reduce the size of the federal ...
9h
GlobalData on MSNMSD’s subcutaneous Keytruda non-inferior to IV version of blockbuster drugCompared to the IV infusion of the blockbuster cancer drug Keytruda, subcutaneous Keytruda can cut the time spent in ...
His areas of experience include handling complex quality control operations, regulatory compliance, and leadership of large ...
Robert F. Kennedy Jr.'s overhaul of federal health agencies will likely impact how Americans get health care, prescription drugs and more.
10h
GlobalData on MSNPantheon Vision taps Eyedeal Medical for corneal implant manufacturingPantheon Vision has signed a deal with Eyedeal Medical to advance the manufacturing of its corneal implants for treating ...
The evidence-backed model delivered impressive results, but it doesn’t validate the wave of AI therapy bots flooding the ...
The high-stakes nature of cancer care, coupled with rapid scientific advancements, increasing payer and regulatory pressures, ...
Preservatives, emulsifiers and other food additives perform pivotal roles in packaged foods. Here’s what you need to know ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results